Mitchell S. Wortzman is EVP at MEDICIS PHARMACEUTICAL CORP (MRX). They have made 5 open-market trades across 1 company since 2008, most recently 2012-12-11.
CIK 0001257586
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| MRX | 203,990 | $14.4M |
Shares reported on the most recent Form 4, priced at the 2012-11-27 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MRX | SELL · 10b5-1 | 2012-11-26 | 2012-11-27 | $43.25 | $6.7M | +2.8% | +2.3% | +2.3% |
| MRX | SELL · 10b5-1 | 2012-11-12 | 2012-11-14 | $42.35 | $494K | +2.8% | +2.3% | +2.3% |
| MRX | SELL · 10b5-1 | 2012-10-31 | 2012-11-02 | $43.35 | $499K | +2.8% | +2.3% | +2.3% |
| MRX | SELL · 10b5-1 | 2012-10-15 | 2012-10-17 | $43.39 | $499K | +2.8% | +2.3% | +2.3% |
| MRX | SELL · 10b5-1 | 2012-10-01 | 2012-10-02 | $43.27 | $498K | +2.8% | +2.3% | +2.3% |
| MRX | SELL · 10b5-1 | 2012-09-17 | 2012-09-18 | $43.49 | $500K | +2.8% | +2.3% | +2.3% |
| MRX | SELL | 2012-08-17 | 2012-08-20 | $32.97 | $659K | +2.8% | +2.3% | +2.3% |
| MRX | SELL | 2011-08-15 | 2011-08-16 | $37.26 | $522K | +2.8% | +2.3% | +2.3% |
| MRX | SELL | 2011-05-16 | 2011-05-18 | $36.78 | $1.9M | +2.8% | +2.3% | +2.3% |
| MRX | SELL | 2009-05-14 | 2009-05-18 | $15.38 | $189K | +2.8% | +2.3% | +2.3% |
| MRX | SELL | 2008-05-21 | 2008-05-22 | $22.92 | $149K | +2.8% | +2.3% | +2.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.